gracecast-113_lung-cancer_asco 2012 lc highlights: dr. neal on anti-pd-1 immunotherapy for nsclc
Published 12 years ago • 1.2K plays • Length 7:41Download video MP4
Download video MP3
Similar videos
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
4:30
gracecast-117_lung-cancer_asco 2012 lc highlights: dr. neal on molecular targets in squamous nsclc
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
7:54
keytruda combined with anti-vegf treatment:use in patients with advanced nsclc-asco lung review 2022
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
42:48
immunotherapy for lung cancer
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
8:03
studies in anti-pd-l1 monotherapy for nsclc - lung cancer onctalk 2022
-
10:39
gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe
-
23:32
gracecast-077_lung-cancer_asco 2011 highlights - advanced/metastatic nsclc
-
5:24
gracecast - lcvl - can immunotherapy help frail patients with advanced nsclc
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
1:44
extended interval dosing for pembrolizumab - lung cancer onctalk 2022
-
1:59:57
grace - global resource for advancing cancer education live stream
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
9:29
gracecast - lcvl - could pre-operative immunotherapy improve outcomes in early stage nsclc
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session
-
23:37
gracecast-103_lung-cancer_immunotherapy: yervoy, anti-pd-1, reolysin, talactoferrin by dr. brahmer